Welcome to Dermagnostix!
At Dermagnostix, we pioneer molecular tests to advance clinical practice and improve patients’ lives.
Spot the impact
One third of the population suffers from at least one skin condition.
Skin diseases impair patients’ quality of life more drastically than cancer and diabetes.
Biologicals and small-molecule inhibitors have created an unprecedented potential for precision medicine. Diagnostics is lagging behind.
Discover our solution
Groundbreaking translational research meets cutting-edge technology – Dermagnostix provides unique diagnostic tests for unmet clinical needs in dermatology on a fully automated portable laboratory.
With PsorX, Dermagnostix launches the first in-class molecular test for differential diagnosis of psoriasis and eczema.
Be one step ahead
Get diagnostic support for hard-to-tackle skin diseases using our simple and fast system:
Sample into LabDisk – LabDisk into Analyzer – Answer out.
Dermagnostix provides molecular diagnostic solution for dermatology.
economic
fast
easy
precise
Learn more about us
Brilliant minds from dermatology, molecular biology, microfluidics engineering and artificial intelligence have joined forces to help patients suffering from skin diseases and stigmatization get accurate diagnoses to improve their quality of life.
Natalie Garzorz-Stark, MD, PhD, MHBA
CEO, Dermatologist
Katharina Dormanns, PhD
Microfluidics Engineer
Prof. Kilian Eyerich, MD, PhD
Dermatologist
Prof. Stefanie Eyerich, PhD
Biologist
Prof. Kristian Reich, MD, PhD
Dermatologist
Prof. Christoffer Gebhardt, MD, PhD
Dermatologist
Prof. Fabian Theis, PhD, PhD
Mathematician, Physicist
Lucca Weber, M.Sc.
Life Science Engineer
PD Nils Paust, PhD
Microfluidics Engineer
News Feed
Funded by